|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Operating expenses: | |||||
| Spaceline operations | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Depreciation and amortization | |||||
| Special charges | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Interest income | |||||
| Change in fair value of warrants | |||||
| Interest expense | |||||
| Debt restructuring expense | |||||
| Other income, net | |||||
| Loss before income taxes | |||||
| Income tax expense | |||||
| Net loss | |||||
| Other comprehensive income (loss): | |||||
| Foreign currency translation adjustment | |||||
| Unrealized loss on marketable securities | |||||
| Total comprehensive loss | |||||
| Net loss per share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted-average shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...